| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
6,394 |
6,372 |
$445K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
5,595 |
5,335 |
$398K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
4,451 |
4,230 |
$271K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
876 |
875 |
$79K |
| 99058 |
|
1,115 |
1,043 |
$71K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
1,454 |
1,394 |
$23K |
| 87428 |
|
338 |
332 |
$9K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
975 |
958 |
$5K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
1,012 |
986 |
$4K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
183 |
180 |
$4K |
| 81002 |
|
1,495 |
1,457 |
$2K |
| 81025 |
|
142 |
140 |
$372.83 |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
75 |
65 |
$231.00 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
123 |
123 |
$66.07 |